Issue 9, 2021

Traditional Chinese medicine (TCM) as a source of new anticancer drugs

Abstract

Covering: up to July 2020

Drugs derived from traditional Chinese medicine (TCM) include both single chemical entities and multi-component preparations. Drugs of both types play a significant role in the healthcare system in China, but are not well-known outside China. The research and development process, the molecular mechanisms of action, and the clinical evaluation associated with some exemplificative anticancer drugs based on TCM are discussed, along with their potential of integration in western medicine.

Graphical abstract: Traditional Chinese medicine (TCM) as a source of new anticancer drugs

Article information

Article type
Review Article
Submitted
03 Aug 2020
First published
29 Jan 2021

Nat. Prod. Rep., 2021,38, 1618-1633

Traditional Chinese medicine (TCM) as a source of new anticancer drugs

C. Yao, J. Zhang, J. Li, W. Wei, S. Wu and D. Guo, Nat. Prod. Rep., 2021, 38, 1618 DOI: 10.1039/D0NP00057D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements